← Browse by Condition
Medical Condition

children

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for children sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — children Clinical Trials

How many clinical trials are currently recruiting for children?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for children, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for children?
children research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a children clinical trial?
Eligibility criteria for children trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Top Sponsors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 1 trial
VitalTracer Ltd. 1 trial
Centre Hospitalier Universitaire, Amiens 1 trial
Charite University, Berlin, Germany 1 trial
Toronto Metropolitan University 1 trial

Recruiting Clinical Trials

NCT06926751 Phase 2
Recruiting

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Enrollment
132 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT05451875
Recruiting

Validation of Vital Signs Recording With VT-Patch Connected Devices in Children

Enrollment
48 pts
Location
Canada
Sponsor
VitalTracer Ltd.
View Trial →
NCT06212609
Recruiting

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies

Enrollment
20 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07193719 Phase 1, Phase 2
Recruiting

Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children

Enrollment
80 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
View Trial →
NCT07231146
Recruiting

Interaction Between Dairy and Gut Hormone Response on Cognitive Performance in Children.

Enrollment
48 pts
Location
Canada
Sponsor
Toronto Metropolitan Universit...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology